[Factors associated with prolonged hospital stay in community-acquired pneumonia]

Enferm Infecc Microbiol Clin. 2009 Mar;27(3):160-4. doi: 10.1016/j.eimc.2008.06.004. Epub 2009 Feb 11.
[Article in Spanish]

Abstract

Introduction: The length of hospital stay in patients with community-acquired pneumonia (CAP) varies considerably, even though this factor has a great impact on the cost of care for this condition. The objective of this study was to identify factors associated with prolonged hospitalization in these patients (>8 days).

Methods: Observational analysis of a prospective cohort of nonimmunosuppressed adults with CAP requiring hospitalization from 1995 through 2006.

Results: We documented a total of 2688 consecutive episodes of CAP. Patients who required intensive care unit admission from the emergency room (n=107), those who died during hospitalization (n=200), and patients hospitalized for more than 30 days (n=60) were excluded from the analysis. The median duration of hospital stay was 8 days (IQR, 6-11). Factors independently associated with prolonged hospital stay by stepwise multiple logistic regression analysis were advanced age (OR=1.58; 95% CI, 1.002-2.503), alcohol abuse (OR=2.07; 95% CI, 1.341-3.199), high-risk Pneumonia Severity Index class (OR=1.72; 95% CI, 1.094-2.703), aspiration pneumonia (OR=4.57; 95% CI, 1.085-19.285), pleural empyema (OR=3.73; 95% CI, 1.978-7.04), and time to clinical stability (OR=1.13; 95% CI, 1.065-1.196).

Conclusions: Several factors that were independently associated with longer hospital stay in adult patients with CAP. These factors should be considered when evaluating the adequacy of the duration of hospitalization in a specific center and when designing future studies investigating new strategies to reduce the length of hospital stay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Alcoholism / epidemiology
  • Anti-Bacterial Agents / therapeutic use
  • Combined Modality Therapy
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / epidemiology*
  • Community-Acquired Infections / therapy
  • Comorbidity
  • Female
  • Hospitals, University / statistics & numerical data
  • Humans
  • Immunocompetence
  • Length of Stay / statistics & numerical data*
  • Male
  • Middle Aged
  • Pleural Effusion / epidemiology
  • Pleural Effusion / etiology
  • Pneumonia / complications
  • Pneumonia / drug therapy
  • Pneumonia / epidemiology*
  • Pneumonia / therapy
  • Prospective Studies
  • Respiration, Artificial / statistics & numerical data
  • Risk Factors
  • Shock, Septic / epidemiology
  • Shock, Septic / etiology
  • Spain / epidemiology

Substances

  • Anti-Bacterial Agents